Topics:
Radiation Oncology • Genitourinary Cancers
Do you recommend ADT for a patient with hypogonadism with unfavorable or high risk prostate cancer whose PSA dropped to <1 after cessation of supplementation?
Is this degree of hypogonadism sufficient to omit leuprolide?
Answer from: Radiation Oncologist at Academic Institution
When I encounter this situation, I will measure the testosterone level off supplementation. If the testosterone is castrate level (<50 ng/dL), then I would not add ADT, as the target testosterone level has already been achieved. If the patient's testosterone level remains above the castrate thres...
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
Not testosterone is at castrate level.